In human T-ALL, a loss of competition may be caused by overexpression of oncogenic transcription factors such as TAL1 and LMO2. Notably, these transcription factors themselves are also involved in the stem cell regulatory program during normal hematopoiesis. This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.